Welcome to our dedicated page for Global Medical REIT news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical REIT stock.
Global Medical REIT Inc. (GMRE) is a Maryland-based real estate investment trust focused on acquiring and leasing specialized healthcare facilities. The company's primary aim is to offer attractive, risk-adjusted returns to its shareholders by providing consistent dividends and promoting long-term capital appreciation. GMRE's portfolio includes purpose-built healthcare facilities leased to physician groups and regional and national healthcare systems.
The company's properties are predominantly located in secondary markets and the suburbs of primary markets, ensuring a diverse geographic footprint. Each facility is generally leased to single tenants under triple-net leases, where the tenant is responsible for most property expenses, providing a steady income stream for GMRE.
Recent achievements include expanding its portfolio of healthcare facilities and strengthening partnerships with leading healthcare systems and physician groups. These strategic acquisitions have bolstered GMRE's position in the healthcare real estate market, reflecting its commitment to growth and stability.
As of the latest updates, GMRE continues to focus on acquiring high-quality, specialized healthcare properties and maintaining strong tenant relationships to ensure sustainable growth. The company has shown resilience in navigating market fluctuations, supported by its solid financial foundation and strategic vision.
Global Medical REIT Inc. (NYSE: GMRE) announced its fourth-quarter 2022 dividends, declaring a cash dividend of
Global Medical REIT Inc. (NYSE: GMRE) invested $51 million in medical real estate during Q3 2022, raising its total investments to $149 million for the year. The company achieved a net income of $8.1 million ($0.12 per diluted share), up from $3.7 million ($0.06) YoY. Revenue increased 18.1% to $35.4 million, driven by acquisitions. The company secured a $150 million term loan, locking in 80% of its debt at fixed rates. Occupancy stands at 97%, reflecting portfolio strength. Dividends for the third quarter were declared at $0.21 per share.
Global Medical REIT Inc. (NYSE: GMRE) announced it will release its third quarter 2022 financial results on November 2, 2022, after the market closes. A conference call to discuss these results is scheduled for November 3, 2022, at 9:00 a.m. Eastern Time. The call will feature key executives including Jeffrey Busch, Robert Kiernan, and Alfonzo Leon. Investors can access the call via a live webcast or by dialing in. Replay options will be available post-call.
Global Medical REIT (NYSE: GMRE) has declared its 2022 third quarter cash dividend of
Global Medical REIT (NYSE: GMRE) reported a net income of $2.2 million or $0.03 per diluted share for Q2 2022, down from $2.6 million or $0.04 per diluted share year-on-year. Funds from Operations (FFO) rose to $16.4 million ($0.24/share), up from $14.1 million ($0.22/share) in Q2 2021. Total revenue increased by 19.2% to $33.7 million due to acquisition activity. The company acquired properties worth $74 million and amended its credit facility to add a $150 million term loan. As of June 30, 2022, portfolio occupancy stood at 96.5%. The company declared a dividend of $0.21 per share for Q2 2022.
Global Medical REIT Inc. (NYSE: GMRE) plans to release its Q2 2022 financial results after market close on August 3, 2022. A conference call to discuss the results will occur on August 4, 2022, at 9:00 a.m. ET. Key executives including Chairman Jeffrey Busch and CFO Robert Kiernan will host the call. Interested parties can access the call via webcast or through a dial-in number. A replay will be available starting at 12:00 p.m. ET on August 4 until midnight on August 18, 2022.
Global Medical REIT (NYSE: GMRE) announced the declaration of its second-quarter dividends for 2022. Shareholders will receive a cash dividend of
Global Medical REIT (NYSE: GMRE) reported a strong first quarter of 2022, with net income attributable to common stockholders reaching $2.7 million, or $0.04 per diluted share, up from $1.8 million in the same period last year. Total revenue rose by 16.5% year-over-year to $31.9 million, driven by four completed acquisitions totaling $24 million at a 7.2% cap rate. Funds from Operations (FFO) and Adjusted Funds from Operations (AFFO) stood at $16.0 million and $16.8 million, respectively. The company remains well-positioned with approximately $1.4 billion in assets and a solid balance sheet.
Global Medical REIT Inc. (NYSE: GMRE) announced its plans to release first quarter 2022 financial results after market close on May 4, 2022. A conference call to discuss these results will be held on May 5, 2022, at 9:00 a.m. Eastern Time, featuring CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the call via a live webcast on the company’s investor website. A replay will be available starting 12:00 p.m. Eastern Time on the same day, lasting until midnight Eastern Time on May 19, 2022.
Global Medical REIT (NYSE: GMRE) has announced its first quarter 2022 cash dividends for common and preferred stock. The common dividend is set at $0.21 per share, payable on April 8, 2022 to stockholders of record by March 25, 2022. Additionally, a quarterly dividend of $0.46875 per share will be paid on Series A Preferred Stock on May 2, 2022, for stockholders recorded by April 15, 2022. GMRE focuses on acquiring and leasing medical office facilities to leading healthcare providers.
FAQ
What is the current stock price of Global Medical REIT (GMRE)?
What is the market cap of Global Medical REIT (GMRE)?
What does Global Medical REIT Inc. do?
Where is Global Medical REIT Inc. based?
What is the primary business objective of Global Medical REIT Inc.?
Where are GMRE's healthcare facilities located?
What type of leases does GMRE use for its properties?
Who are the tenants of GMRE's properties?
What are recent achievements of GMRE?
How does GMRE ensure steady income?
What is the focus of GMRE's current projects?